Post lockdown sees a 37% jump in asthma- and COPD-related ED visits But rebound varies by age with asthmatic children under 5 years seeing an 81% jump in study at Missouri hospitals. Updated recommendation on giving COVID-19 vaccines with other vaccinesThe NACI has announced that COVID-19 vaccines may be administered concurrently with other vaccines in all authorized age groups. Omalizumab in the treatment of asthma: a long-term study First report to assess asthma control upon medication discontinuation in a large cohort of adult and pediatric patients. Using proteomics to better understand cystic fibrosis Study aims to identify potential markers and establish new targets for monitoring the disease. Study shows importance of COVID-19 vaccine booster dose in children 5 to 11 years A booster dose of Pfizer vaccine restored protection against Omicron, with efficacy maintained for at least three months. Nuvaxovid COVID-19 vaccine approved for adolescents and for first booster dose in adults Protein subunit COVID-19 vaccine may be an option for individuals who are unable or not willing to receive an mRNA COVID-19 vaccine. Health Canada approves first bivalent booster for kids ages 5 to 11 The NACI strongly recommends children with weakened immune systems or underlying medical conditions be offered a dose Prescriptions plummeted during the pandemic: study Manitoba study shows sudden drop in all drug classes. Most B.C. kids and adults younger than 60 infected with COVID-19 or vaccinated: study Lead author Dr. Danuta Skowronski, an epidemiologist at the BC Centre for Disease Control, said the findings can be generalized to the rest of Canada. Health Canada reviewing RSV vax for those over 60 As pediatric hospitals fill up with young children sickened by respiratory syncytial virus, doctors are worried that older adults will be the next wave to become seriously ill. First Previous 9 10 11 12 13 Next Last
